-
Mashup Score: 0
It’s time to deep-dive into the trend to see if the science stacks up
Source: Women's HealthCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Anthony A. Bavry, M.D., M.P.H., FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The CHAP trial presented at #ACC22 showed antihypertensive therapy improves pregnancy outcomes among pregnant women with mild chronic #hypertension. Read more about the trial here: https://t.co/xE8Na0CAVZ #ACCCardioOB #CardioObstetrics
-
-
Mashup Score: 24
There’s a swirl of negative health claims around coffee, some as old as time — but how many of them are true? As it turns out, not that many.
Source: Health DigestCategories: Cardiology News and Journals, Latest HeadlinesTweet-
☕ is good for your ❤️ health! A #JACC study presented at #ACC22 found that drinking 2-3 cups of coffee daily was associated with a reduced risk of incident arrhythmia, #CVD and all-cause mortality. Read more in @HealthDigestUS: https://t.co/zwx2uYPFMq #cvPrev
-
-
Mashup Score: 0
The trial achieved its primary efficacy endpoint of terminating PSVT with self-administered etripamil, using symptom-based optional repeat dosing.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
New #ACC22 data show #etripamil demonstrated promising efficacy, safety and tolerability among patients experiencing a PSVT event in the #RAPID trial. Read more here: https://t.co/Tt5G3FPbl4
-
-
Mashup Score: 1
The findings might not be generalizable given a high exclusion rate, variations in practice, and statistical issues, experts say.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Using radial arteries for patients undergoing coronary artery bypass grafting reduces the risk of MACE compared with other graft options, according to results from RAPCO presented at #ACC22. Read the latest from @TCTMD_Yael: https://t.co/kH9EeeNJ7y
-
-
Mashup Score: 0No difference in CV outcomes with two common diuretics among veterans with hypertension - 2 year(s) ago
CHICAGO — Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone, according to new research.In the Diuretic Comparison Project, “chlorthalidone did not reduce the incidence of major cardiovascular outcomes or noncancer death compared to hydrochlorothiazide at
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “We undertook this study as the first large randomized controlled trial comparing chlorthalidone to hydrochlorothiazide,” Ishani said. @Areefishani @VAMinneapolis @American_Heart #ACC22 #CardioTwitter https://t.co/7rODFJZv6M
-
-
Mashup Score: 0No difference in CV outcomes with two common diuretics among veterans with hypertension - 2 year(s) ago
CHICAGO — Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone, according to new research.In the Diuretic Comparison Project, “chlorthalidone did not reduce the incidence of major cardiovascular outcomes or noncancer death compared to hydrochlorothiazide at
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “We undertook this study as the first large randomized controlled trial comparing chlorthalidone to hydrochlorothiazide,” Ishani said. @Areefishani @VAMinneapolis @American_Heart #ACC22 #CardioTwitter https://t.co/7rODFJZv6M
-
-
Mashup Score: 0No difference in CV outcomes with two common diuretics among veterans with hypertension - 2 year(s) ago
CHICAGO — Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone, according to new research.In the Diuretic Comparison Project, “chlorthalidone did not reduce the incidence of major cardiovascular outcomes or noncancer death compared to hydrochlorothiazide at
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Among older veterans with hypertension, there was no difference in the incidence of major adverse CV events after treatment with hydrochlorothiazide compared with chlorthalidone @Areefishani @VAMinneapolis @American_Heart #ACC22 #CardioTwitter https://t.co/7rODFJZv6M
-
-
Mashup Score: 0
Use of hs-cTn mostly didn’t lead to any significant increases in cascade screening and was associated with shorter ED visits.
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Currently, only 1 in 3 hospitals in the US use high-sensitivity cardiac troponin (hs-cTn) assays. But, according to a study presented at #ACC22, that number appears to be increasing. @michaelTCTMD has the latest: https://t.co/fhLLlxS1kD https://t.co/Kquz7mlxO0
-
-
Mashup Score: 1Black Americans Less Likely to Receive Lifesaving CPR: Study - 2 year(s) ago
THURSDAY, Oct. 27, 2022 (HealthDay News) — When someone collapses in front of witnesses, the chances of receiving potentially lifesaving CPR may partly depend on the color of their skin, a new study suggests.Researchers found that when Black and Hispanic Americans suffer cardiac arrest, they are up…
Source: Consumer Health News | HealthDayCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A study presented at #ACC22 & published in @NEJM found that Black & Hispanic Americans suffering #SuddenCardiacArrest are less likely to receive bystander #CPR. Dr. @KBerlacher discusses these findings with @HealthDayTweets: https://t.co/ZFJkiuBewL #HealthEquity
-
A study presented at #ACC22 found that elevated glucose levels were associated with blood vessel damage, which heightens the risk of #HeartDisease. @UKWomensHealth takes a deep dive into the value of measuring blood sugar levels. Read more: https://t.co/dNrcWEL2MP #Diabetes